Cellular preconditioning and mesenchymal stem cell ferroptosis
- PMID: 38455100
- PMCID: PMC10915960
- DOI: 10.4252/wjsc.v16.i2.64
Cellular preconditioning and mesenchymal stem cell ferroptosis
Abstract
In this editorial, we comment on the article published in the recent issue of the World Journal of Stem Cells. They focus on stem cell preconditioning to prevent ferroptosis by modulating the cystathionine γ-lyase/hydrogen sulfide (H2S) pathway as a novel approach to treat vascular disorders, particularly pulmonary hypertension. Preconditioned stem cells are gaining popularity in regenerative medicine due to their unique ability to survive by resisting the harsh, unfavorable microenvironment of the injured tissue. They also secrete various paracrine factors against apoptosis, necrosis, and ferroptosis to enhance cell survival. Ferroptosis, a regulated form of cell death characterized by iron accumulation and oxidative stress, has been implicated in various pathologies encompassing degenerative disorders to cancer. The lipid peroxidation cascade initiates and sustains ferroptosis, generating many reactive oxygen species that attack and damage multiple cellular structures. Understanding these intertwined mechanisms provides significant insights into developing therapeutic modalities for ferroptosis-related diseases. This editorial primarily discusses stem cell preconditioning in modulating ferroptosis, focusing on the cystathionase gamma/H2S ferroptosis pathway. Ferroptosis presents a significant challenge in mesenchymal stem cell (MSC)-based therapies; hence, the emerging role of H2S/cystathionase gamma/H2S signaling in abrogating ferroptosis provides a novel option for therapeutic intervention. Further research into understanding the precise mechanisms of H2S-mediated cytoprotection against ferroptosis is warranted to enhance the therapeutic potential of MSCs in clinical settings, particularly vascular disorders.
Keywords: Cell survival; Cell therapy; Ferroptosis; Hydrogen sulfide; Preconditioning; Stem cells; Umbilical cord.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article.
Figures

Similar articles
-
Dissecting molecular mechanisms underlying ferroptosis in human umbilical cord mesenchymal stem cells: Role of cystathionine γ-lyase/hydrogen sulfide pathway.World J Stem Cells. 2023 Nov 26;15(11):1017-1034. doi: 10.4252/wjsc.v15.i11.1017. World J Stem Cells. 2023. PMID: 38058959 Free PMC article.
-
Hydrogen sulfide guards myoblasts from ferroptosis by inhibiting ALOX12 acetylation.Cell Signal. 2021 Feb;78:109870. doi: 10.1016/j.cellsig.2020.109870. Epub 2020 Dec 5. Cell Signal. 2021. PMID: 33290842
-
Sodium hydrosulfide inhibits hemin-induced ferroptosis and lipid peroxidation in BV2 cells via the CBS/H2S system.Cell Signal. 2023 Apr;104:110594. doi: 10.1016/j.cellsig.2023.110594. Epub 2023 Jan 13. Cell Signal. 2023. PMID: 36646297
-
Mesenchymal stem cells and ferroptosis: Clinical opportunities and challenges.Heliyon. 2024 Feb 3;10(3):e25251. doi: 10.1016/j.heliyon.2024.e25251. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38356500 Free PMC article. Review.
-
Emerging relationship between hydrogen sulfide and ferroptosis: A literature review.Acta Biochim Pol. 2023 Dec 7;70(4):735-744. doi: 10.18388/abp.2020_6756. Acta Biochim Pol. 2023. PMID: 38060814 Review.
Cited by
-
LncRNA AK020546 Alleviates Myocardial Ischemia-Reperfusion Injury via Suppressing METTL14/m6A/MST1 Axis-Mediated Ferroptosis.Cardiovasc Toxicol. 2025 Aug;25(8):1169-1180. doi: 10.1007/s12012-025-10019-1. Epub 2025 Jun 4. Cardiovasc Toxicol. 2025. PMID: 40465027
-
Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges.Signal Transduct Target Ther. 2024 Sep 13;9(1):242. doi: 10.1038/s41392-024-01936-8. Signal Transduct Target Ther. 2024. PMID: 39271680 Free PMC article. Review.
-
Tissue-source effect on mesenchymal stem cells as living biodrugs for heart failure: Systematic review and meta-analysis.World J Cardiol. 2024 Aug 26;16(8):469-483. doi: 10.4330/wjc.v16.i8.469. World J Cardiol. 2024. PMID: 39221190 Free PMC article.
-
Priming mesenchymal stem cells to develop "super stem cells".World J Stem Cells. 2024 Jun 26;16(6):623-640. doi: 10.4252/wjsc.v16.i6.623. World J Stem Cells. 2024. PMID: 38948094 Free PMC article.
-
Melatonin-based priming of stem cells to alleviate oxidative stress.World J Stem Cells. 2024 Nov 26;16(11):985-989. doi: 10.4252/wjsc.v16.i11.985. World J Stem Cells. 2024. PMID: 39619873 Free PMC article.
References
-
- Liu S, Liu X, Xian J, Feng Z, Tian Y, Wang W, Tian X. Visualizing intracellular membrane interactions and cell type-specific differentiation in ferroptosis and apoptosis with Boranil-Carbazole derivative. Bioorg Chem. 2024;142:106949. - PubMed
Publication types
LinkOut - more resources
Full Text Sources